Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …

Liver injury, characterized predominantly by elevated aspartate aminotransferase and
alanine aminotransferase, is a common feature of coronavirus disease 2019 (COVID‐19) …

Background Repurposing the use of aspirin to treat hospitalized patients with COVID-19 is a
sensible approach. However, several previous studies showed conflicting results. This meta …

The COVID-19 pandemic examines not only the state of actual health care but also the state
of fundamental medicine in various countries. Pro-inflammatory processes extend far …

COVID‐19 infection, affecting every one of us from the last year. Emerging reports have
indicated thromboembolism in serious cases of COVID‐19. The aspirin is useful to reduce …

Abstract Purpose of Review Coronavirus disease 2019 (COVID19) involves the heart,
including pericardium. This article reviews the possible pathophysiological mechanisms in …

Globally, there have been close to 130 million reported cases of coronavirus disease 2019
(COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce …

Brain organoids are self-assembled three-dimensional aggregates with brain-like cell types
and structures and have emerged as new model systems that can be used to investigate …

Acetylsalicylic acid (ASA) is one of the first drugs to be obtained by synthesis while being the
most used. It has experienced the longest lasting commercial success and is considered the …

Aim Recent reports of potential harmful effects of nonsteroidal anti‐inflammatory drugs
(NSAIDs) in treating patients with coronavirus disease 2019 (COVID‐19) have raised great …